Abbott Laboratories (ABT)
106.71
-0.18
(-0.17%)
USD |
NYSE |
Apr 25, 12:38
Abbott Laboratories Net Income (TTM): 5.63B for March 31, 2024
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 5.63B |
| December 31, 2023 | 5.723B |
| September 30, 2023 | 5.162B |
| June 30, 2023 | 5.161B |
| March 31, 2023 | 5.804B |
| December 31, 2022 | 6.933B |
| September 30, 2022 | 7.889B |
| June 30, 2022 | 8.554B |
| March 31, 2022 | 7.725B |
| December 31, 2021 | 7.071B |
| September 30, 2021 | 7.244B |
| June 30, 2021 | 6.376B |
| March 31, 2021 | 5.724B |
| December 31, 2020 | 4.495B |
| September 30, 2020 | 3.382B |
| June 30, 2020 | 3.11B |
| March 31, 2020 | 3.579B |
| December 31, 2019 | 3.687B |
| September 30, 2019 | 3.292B |
| June 30, 2019 | 2.895B |
| March 31, 2019 | 2.622B |
| December 31, 2018 | 2.368B |
| September 30, 2018 | 886.00M |
| June 30, 2018 | 926.00M |
| March 31, 2018 | 476.00M |
| Date | Value |
|---|---|
| December 31, 2017 | 477.00M |
| September 30, 2017 | 2.103B |
| June 30, 2017 | 1.171B |
| March 31, 2017 | 1.503B |
| December 31, 2016 | 1.40B |
| September 30, 2016 | 1.369B |
| June 30, 2016 | 2.278B |
| March 31, 2016 | 2.447B |
| December 31, 2015 | 4.423B |
| September 30, 2015 | 4.56B |
| June 30, 2015 | 4.518B |
| March 31, 2015 | 4.20B |
| December 31, 2014 | 2.283B |
| September 30, 2014 | 1.968B |
| June 30, 2014 | 2.396B |
| March 31, 2014 | 2.406B |
| December 31, 2013 | 2.575B |
| September 30, 2013 | 3.039B |
| June 30, 2013 | 4.016B |
| March 31, 2013 | 5.265B |
| December 31, 2012 | 5.963B |
| September 30, 2012 | 6.528B |
| June 30, 2012 | 4.888B |
| March 31, 2012 | 5.106B |
| December 31, 2011 | 4.728B |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
2.895B
Minimum
Jun 2019
8.554B
Maximum
Jun 2022
5.472B
Average
5.676B
Median
Net Income (TTM) Benchmarks
| Boston Scientific Corp | 1.593B |
| Stryker Corp | 3.165B |
| Intuitive Surgical Inc | 1.988B |
| Insulet Corp | 206.30M |
| Edwards Lifesciences Corp | 1.402B |